Accelrys ($ACCL) has beefed up its software offerings for virtual biotech teams. The San Diego-based company has acquired technology and personnel from drug developer Scynexis related to an SaaS product called Hit Explorer Operating System.
John Sculley believes that cloud computing and big data analytics have the potential to solve some of the largest problems in healthcare, including mounting costs, The Guardian reported.
Knode has sprung to life with web-based software to enable life sciences stakeholders to hunt for top experts.
Sold on the growing need for data in biopharma, India's Piramal Healthcare has scooped up Decision Resources Group in deal valued at about $635 million.
As we pack more data about our health into mobile devices, pharma companies could face a new competitive threat to their drugs: Mobile health apps.
As GenomeWeb reports, the National Institutes of Health's National Institute on Aging has heeded the president's call for action and awarded up to $6 million for three projects that aim to analyze DNA sequencing data related to Alzheimer's.
BioClinica ($BIOC) capitalized on the compatibility of its clinical trials software with Microsoft ($MSFT) technology and boosted revenue and income during the first quarter that ended March 31, the company said last week.
Boehringer Ingelheim wants to create a social game dubbed "Syrum" that would let players tend to virtual R&D projects and traffic in scientific talent and compounds, according to InPharm.
Roche's 454 Life Sciences has struck a partnership with SoftGenetics, a provider of next-generation sequencing (NGS) analytics. The co-op calls for Roche/454 and SoftGenetics to join forces in production promotions, the software company says.
In an effort to engineer a turnaround at the struggling giant, AstraZeneca has zeroed in on information technology projects that could deliver results. And Angela Yochem, the company's technology chief since last year, has been digging into the miscues at the global company.
De Vries and I have spoken several times over the past year about how cloud computing and other innovations are changing the way clinical trials data and operations are managed. We recently agreed to host one such chat in the Twitterverse.
Designed at UCLA with the non-scientist in mind, a game allows players to separate healthy from infected blood cells to diagnose malaria.
Oxford Nanopore has grabbed $50.8 million in a fresh round of financing as the U.K. company advances plans to compete in the DNA sequencing game with small device that could expand applications of the technology.
Bina Technologies is betting on the combination of computer hardware and software to become a success in the genomics field.
Cambridge, MA-based Sproxil, which provides tech to combat drug counterfeiting to Merck and GlaxoSmithKline, says the company has harnessed IBM's cloud computing and visualization software to improve its product.
Australian researchers argue that open source rules for clinical trials could nix the replication and stymied progress which result from keeping data from studies under wraps.
Genomics was a hot topic last week at the Bio-IT World Expo, as tech companies and service providers highlighted their tools and hardware for exploring and interpreting the genome.
The company wrapped up the first quarter of 2012 with record revenue of $50.4 million and a 76% jump in GAAP operating income to $6.1 million.
BT Global has run to the market with a cloud-based service that allows biopharma companies to conduct global collaborations.
Drugmakers are pouring more money into online outreach and marketing, and several of the largest pharma companies have been rewarded for good stewardship of their web presences.